Viewing StudyNCT02289222



Ignite Creation Date: 2024-05-06 @ 3:25 AM
Last Modification Date: 2024-10-26 @ 11:33 AM
Study NCT ID: NCT02289222
Status: TERMINATED
Last Update Posted: 2019-11-05
First Post: 2014-10-17

Brief Title: 1454GCC Anti-PD-1 MK-3475 and IMiD Pomalidomide Combination Immunotherapy in RelapsedRefractory Multiple Myeloma
Sponsor: Ashraf Badros
Organization: University of Maryland Baltimore

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-12-30
Start Date Type: ACTUAL
Primary Completion Date: 2017-08-07
Primary Completion Date Type: ACTUAL
Completion Date: 2017-08-07
Completion Date Type: ACTUAL
First Submit Date: 2014-10-17
First Submit QC Date: November 12 2014
Study First Post Date: 2014-11-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2018-08-01
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-11-01
Last Update Post Date: 2019-11-05
Last Update Post Date Type: ACTUAL